Author: Staff

Immunotherapy company 3T Biosciences has named John Leonard, MD, to its board of directors. 

New York City-based Albert Einstein College of Medicine has named Lynne Holden, MD, as a senior associate dean for diversity and inclusion.

Digital health company UpHealth has named Dr. Mahesh Inder Veer Singh executive vice president.

Theseus Pharmaceuticals, a biopharmaceutical company focused on developing drugs for cancer patients, has appointed Steven Stein, MD, to its board of directors. 

Versanis Bio, a company that creates therapeutics used in the treatment of obesity and cardiometabolic diseases, has named Kenneth Attie, MD, chief medical officer and executive vice president.

Biotech company Revance has named David Hollander, MD, as its chief medical officer in charge of clinical development, data science, medical affairs, innovation and regulatory affairs.

Here are 10 CEO appointments Becker's has reported on since Oct. 7:

A recent study found that the FDA's customary Friday drug safety alerts could prevent more deaths and drug complications if they occurred on other weekdays.

Oncology company IconOVir has appointed Julia Maltzman, MD, as the company's chief medical officer.

Timothy Jacobs, DO, has retired from Quincy (Ill.) Medical Group after 29 years at the practice, according to Oct. 7 reporting in The Herald-Whig.